It’s More Than a Career, It’s a Mission.

Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.

Our Mission

People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.

The Research Manager is responsible for the overall research data operations  in the Phase I solid tumor Drug Development Unit and the Colorado Blood Cancer Institute research program.

You will be responsible for the overall research data

You will oversee clinical trial-related activities completed/performed by the research staff to ensure completeness and accuracy as well as adherence to federal and state guidelines. 

You will problem solve clinical situations along with the research staff and the management team as they arise.  

You will assess the organizational processes associated with trial execution and identifies ways to improve and streamline internal procedures.  

You will plan, facilitate, and present trial management issues and data status updates at internal and external meetings.  

You will provide oversight, leadership, and direction in the management and execution of trials.  

You will assess quality of data and performance of clinical trials and develops action plans to address performance gaps.  

You will manage, monitor, and operate within allowed budget.  

You will review of all program billing outcomes and for working with billing staff and Sarah Cannon in addressing issues impacting financial outcomes and patient billing experience.  

You will work to ensure successful implementation of the EMR and optimization of clinic processes related to OncoEMR implementation to support clinic outcomes and patient experience.  

You will promote communication and accountability between staff and physicians.  

You will monitor billing colleagues and services, provides financial reports and completes financial analysis to determine areas for improvement in financial outcomes.  

You will maintain competency and enhance professional growth and development through continuing education, conferences, and seminars.  

You will enhance operational effectiveness, emphasizing cost containment without jeopardizing innovation of quality of care.  

You will oversee all aspects of patient treatment associated with trial execution, including enrollment, patient consent, lab work, data entry, and drug storage/distribution. 

You will keep the executive team abreast of issues, progress, and risks related to trial operations and the overall clinic and you will meets frequently with all investigators.  

You will assist in developing and executing internal and external strategies. You are responsible for the recruitment, hiring, training, development, and termination of colleagues, as necessary.  

You should have for this role: 

A Bachelor’s Degree is required 

Knowledge of FDA guidelines and GCP. 

Must be able to read, understand and comply with research protocols.  

Experience using clinical trial databases, electronic data capture, MS Access and MS Excel.  

At least three years of experience in an oncology setting 

It is preferred that you have: 

At least one year of experience supervising or managing others 

At least one year of experience in blood cancer/Bone Marrow Transplant (BMT) 

Research Certification (ACRP or CCRP) preferred 

About Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.

We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.

As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.